Articles from Polarean

Polarean’s FDA cleared coil achieves important milestone, expanding clinical reach

Expanding commercial reach and advancing lung imaging innovation in Asia-Pacific

Increases number of eligible patients by approximately one million

30+ studies across diverse conditions illuminate the unique value of functional lung imaging with Xenon MRI

One of the largest US outpatient medical imaging providers to introduce Xenon MRI platform to its network

Expands accessibility for institutions utilizing GE HealthCare MRI systems

Experienced business leader with extensive commercial experience in Magnetic Resonance Imaging

Adds significant pulmonary expertise to help drive engagement with the medical community

Financing led by existing and new investors

Featured Company at Respiratory Innovation Summit to Jump Start Robust Presence

Two best-in-class lung imaging companies combine expertise for the deployment of a new xenon 129 MRI platform.

The code is effective as of October 1, 2023

Additional clearance for new MRI chest coil further supports the recently announced collaboration with Philips.